BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND PTCH1, RP11-435O5_3, Q13635, PTCH, 5727, HPE7, FLJ26746, NBCCS, BCNS, PTC1, ENSG00000185920, FLJ42602 AND Clinical Outcome
8 results:

  • 1. Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors.
    Necchi A; Bratslavsky G; Shapiro O; Elvin JA; Vergilio JA; Killian JK; Ngo N; Ramkissoon S; Severson E; Hemmerich AC; Ali SM; Chung JH; Reddy P; Miller VA; Schrock AB; Gay LM; Ross JS; Jacob JM
    Eur Urol Focus; 2019 Sep; 5(5):748-755. PubMed ID: 31147264
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
    Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
    Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ptch 1 staining of pancreatic neuroendocrine tumor (PNET) samples from patients with and without multiple endocrine neoplasia (MEN-1) syndrome reveals a potential therapeutic target.
    Gurung B; Hua X; Runske M; Bennett B; LiVolsi V; Roses R; Fraker DA; Metz DC
    Cancer Biol Ther; 2015; 16(2):219-24. PubMed ID: 25482929
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The prevalence of RET/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors.
    Erdoğan M; Berdeli A; Karadeniz M; Ertan Y; Cetinkalp S; Saygili F; Tuncyurek M; Yilmaz C; Tuzun M; Kabalak T; Uluer H; Ozgen AG
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):225-30. PubMed ID: 18393128
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.
    Brzeziańska E; Karbownik M; Migdalska-Sek M; Pastuszak-Lewandoska D; Włoch J; Lewiński A
    Mutat Res; 2006 Jul; 599(1-2):26-35. PubMed ID: 16483615
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas.
    Puxeddu E; Moretti S; Giannico A; Martinelli M; Marino C; Avenia N; Cristofani R; Farabi R; Reboldi G; Ribacchi R; Pontecorvi A; Santeusanio F
    Eur J Endocrinol; 2003 May; 148(5):505-13. PubMed ID: 12720532
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Rearrangement of the RET gene in papillary thyroid carcinoma].
    Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome.
    Kjellman P; Learoyd DL; Messina M; Weber G; Höög A; Wallin G; Larsson C; Robinson BG; Zedenius J
    Br J Surg; 2001 Apr; 88(4):557-63. PubMed ID: 11298625
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.